Financhill
Sell
25

XAIR Quote, Financials, Valuation and Earnings

Last price:
$0.30
Seasonality move :
-19.49%
Day range:
$0.28 - $0.32
52-week range:
$0.24 - $1.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.85x
P/B ratio:
1.35x
Volume:
1.4M
Avg. volume:
1.6M
1-year change:
-80.45%
Market cap:
$23.7M
Revenue:
$1.2M
EPS (TTM):
-$1.06

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
XAIR
Beyond Air
$929.6K -- 195.4% -- $2.25
CVRX
CVRx
$15.2M -$0.38 36.28% -49.78% $19.83
NMTC
NeuroOne Medical Technologies
-- -- 157.41% -57.14% --
NTRB
Nutriband
$710K -$0.12 -- -- $13.00
NVNO
enVVeno Medical
-- -$0.35 -- -26.67% $16.50
SINT
SINTX Technologies
$700K -$5.29 20.07% -96.14% $300.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
XAIR
Beyond Air
$0.27 $2.25 $23.7M -- $0.00 0% 4.85x
CVRX
CVRx
$11.75 $19.83 $305.9M -- $0.00 0% 5.18x
NMTC
NeuroOne Medical Technologies
$1.08 -- $33.3M -- $0.00 0% 5.35x
NTRB
Nutriband
$6.57 $13.00 $73M -- $0.00 0% 32.20x
NVNO
enVVeno Medical
$2.93 $16.50 $51.4M -- $0.00 0% 268.98x
SINT
SINTX Technologies
$3.42 $300.00 $4.6M -- $0.00 0% 0.94x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
XAIR
Beyond Air
0.34% 1.443 0.22% 2.15x
CVRX
CVRx
40.95% 1.549 15.36% 10.70x
NMTC
NeuroOne Medical Technologies
-- -2.513 -- 2.23x
NTRB
Nutriband
1.68% 4.975 0.28% 4.65x
NVNO
enVVeno Medical
-- -0.506 -- --
SINT
SINTX Technologies
2.35% -1.062 3.06% 2.48x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
XAIR
Beyond Air
-$215K -$11M -151.32% -225.36% -1192.54% -$8.3M
CVRX
CVRx
$12.8M -$10.3M -57.66% -89.85% -59.98% -$8.1M
NMTC
NeuroOne Medical Technologies
$1.9M $1.7M -238.93% -238.93% 64.45% $183.6K
NTRB
Nutriband
$191K -$1.4M -65.19% -69.58% -210.38% -$1.1M
NVNO
enVVeno Medical
-- -$6.7M -- -- -- -$5.1M
SINT
SINTX Technologies
$157K -$2M -130.78% -132.95% -1697.55% -$2.6M

Beyond Air vs. Competitors

  • Which has Higher Returns XAIR or CVRX?

    CVRx has a net margin of -1215.67% compared to Beyond Air's net margin of -69.42%. Beyond Air's return on equity of -225.36% beat CVRx's return on equity of -89.85%.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air
    -20.06% -$0.15 $18.4M
    CVRX
    CVRx
    83.24% -$0.43 $120.3M
  • What do Analysts Say About XAIR or CVRX?

    Beyond Air has a consensus price target of $2.25, signalling upside risk potential of 736.74%. On the other hand CVRx has an analysts' consensus of $19.83 which suggests that it could grow by 68.79%. Given that Beyond Air has higher upside potential than CVRx, analysts believe Beyond Air is more attractive than CVRx.

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air
    1 1 0
    CVRX
    CVRx
    5 1 0
  • Is XAIR or CVRX More Risky?

    Beyond Air has a beta of 0.160, which suggesting that the stock is 83.96% less volatile than S&P 500. In comparison CVRx has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock XAIR or CVRX?

    Beyond Air has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air pays -- of its earnings as a dividend. CVRx pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XAIR or CVRX?

    Beyond Air quarterly revenues are $1.1M, which are smaller than CVRx quarterly revenues of $15.3M. Beyond Air's net income of -$13M is lower than CVRx's net income of -$10.7M. Notably, Beyond Air's price-to-earnings ratio is -- while CVRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air is 4.85x versus 5.18x for CVRx. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air
    4.85x -- $1.1M -$13M
    CVRX
    CVRx
    5.18x -- $15.3M -$10.7M
  • Which has Higher Returns XAIR or NMTC?

    NeuroOne Medical Technologies has a net margin of -1215.67% compared to Beyond Air's net margin of 54.53%. Beyond Air's return on equity of -225.36% beat NeuroOne Medical Technologies's return on equity of -238.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air
    -20.06% -$0.15 $18.4M
    NMTC
    NeuroOne Medical Technologies
    58.85% $0.06 $2.9M
  • What do Analysts Say About XAIR or NMTC?

    Beyond Air has a consensus price target of $2.25, signalling upside risk potential of 736.74%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of -- which suggests that it could grow by 85.19%. Given that Beyond Air has higher upside potential than NeuroOne Medical Technologies, analysts believe Beyond Air is more attractive than NeuroOne Medical Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air
    1 1 0
    NMTC
    NeuroOne Medical Technologies
    0 0 0
  • Is XAIR or NMTC More Risky?

    Beyond Air has a beta of 0.160, which suggesting that the stock is 83.96% less volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.659, suggesting its less volatile than the S&P 500 by 34.118%.

  • Which is a Better Dividend Stock XAIR or NMTC?

    Beyond Air has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XAIR or NMTC?

    Beyond Air quarterly revenues are $1.1M, which are smaller than NeuroOne Medical Technologies quarterly revenues of $3.3M. Beyond Air's net income of -$13M is lower than NeuroOne Medical Technologies's net income of $1.8M. Notably, Beyond Air's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air is 4.85x versus 5.35x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air
    4.85x -- $1.1M -$13M
    NMTC
    NeuroOne Medical Technologies
    5.35x -- $3.3M $1.8M
  • Which has Higher Returns XAIR or NTRB?

    Nutriband has a net margin of -1215.67% compared to Beyond Air's net margin of -211%. Beyond Air's return on equity of -225.36% beat Nutriband's return on equity of -69.58%.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air
    -20.06% -$0.15 $18.4M
    NTRB
    Nutriband
    29.58% -$0.12 $11.4M
  • What do Analysts Say About XAIR or NTRB?

    Beyond Air has a consensus price target of $2.25, signalling upside risk potential of 736.74%. On the other hand Nutriband has an analysts' consensus of $13.00 which suggests that it could grow by 97.87%. Given that Beyond Air has higher upside potential than Nutriband, analysts believe Beyond Air is more attractive than Nutriband.

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air
    1 1 0
    NTRB
    Nutriband
    1 0 0
  • Is XAIR or NTRB More Risky?

    Beyond Air has a beta of 0.160, which suggesting that the stock is 83.96% less volatile than S&P 500. In comparison Nutriband has a beta of 0.695, suggesting its less volatile than the S&P 500 by 30.457%.

  • Which is a Better Dividend Stock XAIR or NTRB?

    Beyond Air has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air pays -- of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XAIR or NTRB?

    Beyond Air quarterly revenues are $1.1M, which are larger than Nutriband quarterly revenues of $645.8K. Beyond Air's net income of -$13M is lower than Nutriband's net income of -$1.4M. Notably, Beyond Air's price-to-earnings ratio is -- while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air is 4.85x versus 32.20x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air
    4.85x -- $1.1M -$13M
    NTRB
    Nutriband
    32.20x -- $645.8K -$1.4M
  • Which has Higher Returns XAIR or NVNO?

    enVVeno Medical has a net margin of -1215.67% compared to Beyond Air's net margin of --. Beyond Air's return on equity of -225.36% beat enVVeno Medical's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air
    -20.06% -$0.15 $18.4M
    NVNO
    enVVeno Medical
    -- -$0.30 --
  • What do Analysts Say About XAIR or NVNO?

    Beyond Air has a consensus price target of $2.25, signalling upside risk potential of 736.74%. On the other hand enVVeno Medical has an analysts' consensus of $16.50 which suggests that it could grow by 463.14%. Given that Beyond Air has higher upside potential than enVVeno Medical, analysts believe Beyond Air is more attractive than enVVeno Medical.

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air
    1 1 0
    NVNO
    enVVeno Medical
    1 0 0
  • Is XAIR or NVNO More Risky?

    Beyond Air has a beta of 0.160, which suggesting that the stock is 83.96% less volatile than S&P 500. In comparison enVVeno Medical has a beta of 1.377, suggesting its more volatile than the S&P 500 by 37.658%.

  • Which is a Better Dividend Stock XAIR or NVNO?

    Beyond Air has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XAIR or NVNO?

    Beyond Air quarterly revenues are $1.1M, which are larger than enVVeno Medical quarterly revenues of --. Beyond Air's net income of -$13M is lower than enVVeno Medical's net income of -$6.2M. Notably, Beyond Air's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air is 4.85x versus 268.98x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air
    4.85x -- $1.1M -$13M
    NVNO
    enVVeno Medical
    268.98x -- -- -$6.2M
  • Which has Higher Returns XAIR or SINT?

    SINTX Technologies has a net margin of -1215.67% compared to Beyond Air's net margin of -1700%. Beyond Air's return on equity of -225.36% beat SINTX Technologies's return on equity of -132.95%.

    Company Gross Margin Earnings Per Share Invested Capital
    XAIR
    Beyond Air
    -20.06% -$0.15 $18.4M
    SINT
    SINTX Technologies
    42.78% -$6.96 $5.7M
  • What do Analysts Say About XAIR or SINT?

    Beyond Air has a consensus price target of $2.25, signalling upside risk potential of 736.74%. On the other hand SINTX Technologies has an analysts' consensus of $300.00 which suggests that it could grow by 1946.78%. Given that SINTX Technologies has higher upside potential than Beyond Air, analysts believe SINTX Technologies is more attractive than Beyond Air.

    Company Buy Ratings Hold Ratings Sell Ratings
    XAIR
    Beyond Air
    1 1 0
    SINT
    SINTX Technologies
    0 1 0
  • Is XAIR or SINT More Risky?

    Beyond Air has a beta of 0.160, which suggesting that the stock is 83.96% less volatile than S&P 500. In comparison SINTX Technologies has a beta of 1.201, suggesting its more volatile than the S&P 500 by 20.05%.

  • Which is a Better Dividend Stock XAIR or SINT?

    Beyond Air has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air pays -- of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XAIR or SINT?

    Beyond Air quarterly revenues are $1.1M, which are larger than SINTX Technologies quarterly revenues of $367K. Beyond Air's net income of -$13M is lower than SINTX Technologies's net income of -$6.2M. Notably, Beyond Air's price-to-earnings ratio is -- while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air is 4.85x versus 0.94x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XAIR
    Beyond Air
    4.85x -- $1.1M -$13M
    SINT
    SINTX Technologies
    0.94x -- $367K -$6.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Is Ford Stock Undervalued Amid the EV Transition?
Is Ford Stock Undervalued Amid the EV Transition?

There is a lot going on in the electric vehicle…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
48
SMTC alert for Mar 18

Semtech [SMTC] is down 0.49% over the past day.

Buy
67
PLPC alert for Mar 18

Preformed Line Products [PLPC] is up 3.8% over the past day.

Buy
58
NUTX alert for Mar 18

Nutex Health [NUTX] is up 4.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock